These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1856144)

  • 21. Comparison of the efficacy and safety of isepamicin and amikacin in the treatment of acute lower respiratory tract infections caused by gram-negative organisms.
    Covi M; Velluti G
    J Chemother; 1995 Jun; 7 Suppl 2():137-42. PubMed ID: 8622102
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Once-daily aminoglycosides in patients with neutropenic fever.
    Aiken SK; Wetzstein GA
    Cancer Control; 2002; 9(5):426-31. PubMed ID: 12410181
    [No Abstract]   [Full Text] [Related]  

  • 23. Once-daily aminoglycoside dosing.
    Baxter R
    Ann Intern Med; 1997 Feb; 126(4):330. PubMed ID: 9036808
    [No Abstract]   [Full Text] [Related]  

  • 24. [Amikacin--a semisynthetic aminoglycoside of the III generation].
    Kuznetsova SM
    Antibiot Khimioter; 2002; 47(5):30-41. PubMed ID: 12365326
    [No Abstract]   [Full Text] [Related]  

  • 25. Cost-effectiveness of ceftriaxone and amikacin as single daily dose for the empirical management of febrile granulocytopenic children with cancer.
    Pession A; Prete A; Paolucci G
    Chemotherapy; 1997; 43(5):358-66. PubMed ID: 9309370
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cefoperazone-sulbactam for treatment of intra-abdominal infections: results from a randomized, parallel group study in India.
    Chandra A; Dhar P; Dharap S; Goel A; Gupta R; Hardikar JV; Kapoor VK; Mathur AK; Modi P; Narwaria M; Ramesh MK; Ramesh H; Sastry RA; Shah S; Virk S; Sudheer OV; Sreevathsa MR; Varshney S; Kochhar P; Somasundaram S; Desai C; Schou M
    Surg Infect (Larchmt); 2008 Jun; 9(3):367-76. PubMed ID: 18570578
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Microorganisms isolated in 54 patients receiving bone marrow transplants and evaluation of their sensitivity to antimicrobial agents].
    Valls A; Grañena A; Carreras E; Almela M; Jiménez de Anta MT; Marín P; Rozman C
    Med Clin (Barc); 1987 Nov; 89(18):768-72. PubMed ID: 3323696
    [No Abstract]   [Full Text] [Related]  

  • 28. Acute kidney injury in patients using amikacin in an era of carbapenem-resistant bacteria.
    Tuon FF; Aragao BZ; Santos TA; Gasparetto J; Cordova K; Abujamra M
    Infect Dis (Lond); 2016; 48(11-12):869-71. PubMed ID: 27389520
    [No Abstract]   [Full Text] [Related]  

  • 29. [Antibiotic-induced diseases. Aminoglycoside-induced renal lesions].
    Gioannini P
    Minerva Med; 1978 Dec; 69(61):4215-25. PubMed ID: 366465
    [No Abstract]   [Full Text] [Related]  

  • 30. The efficacy and toxicity of two dosing-regimens of amikacin in neonates with sepsis.
    Abdel-Hady E; El Hamamsy M; Hedaya M; Awad H
    J Clin Pharm Ther; 2011 Feb; 36(1):45-52. PubMed ID: 21198719
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ceftriaxone versus ceftazidime plus aminoglycoside therapy for infections in patients with neutropenia after cytotoxic chemotherapy. Short communication.
    Krcméry V; Danisovicová A; Drgona L; Spánik S; Fuchsberger P; Korec S; Svec J
    Neoplasma; 1993; 40(2):103-5. PubMed ID: 8350953
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Once-daily dosing of aminoglycoside antibiotics.
    Fisman DN; Kaye KM
    Infect Dis Clin North Am; 2000 Jun; 14(2):475-87. PubMed ID: 10829267
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapeutic drug monitoring of aminoglycosides in acute myeloid leukaemia patients.
    Mareville J; Gay J; Cliquennois E; Herbaux C; Pasquier F; Allorge D; Blondiaux N; Berthon C; Alfandari S
    Scand J Infect Dis; 2012 May; 44(5):398-401. PubMed ID: 22235869
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of the efficacy and safety of isepamicin compared with amikacin in the treatment of nosocomial pneumonia and septicaemia.
    Beaucaire G
    J Chemother; 1995 Jun; 7 Suppl 2():165-73. PubMed ID: 8622107
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A prospective comparative study of gentamicin- and amikacin-induced nephrotoxicity in patients with normal baseline renal function.
    Sweileh WM
    Fundam Clin Pharmacol; 2009 Aug; 23(4):515-20. PubMed ID: 19709328
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Empiric antibiotic therapy for granulocytopenic cancer patients.
    Schimpff SC
    Am J Med; 1986 May; 80(5C):13-20. PubMed ID: 3521270
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aminoglycoside antibiotic agents: a review.
    Spelman DW; McDonald M; Spicer WJ
    Med J Aust; 1989 Sep; 151(6):346-9. PubMed ID: 2687667
    [No Abstract]   [Full Text] [Related]  

  • 38. Once-daily administration of aminoglycosides.
    Bates RD; Nahata MC
    Ann Pharmacother; 1994 Jun; 28(6):757-66. PubMed ID: 7919568
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The aminoglycosides. Streptomycin, kanamycin, gentamicin, tobramycin, amikacin, netilmicin, sisomicin.
    Edson RS; Keys TF
    Mayo Clin Proc; 1983 Feb; 58(2):99-102. PubMed ID: 6823164
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Randomized clinical trial comparing ceftriaxone/amikacin versus ceftazidime/amikacin as initial therapy of febrile episodes in neutropenic patients.
    Yataganas X; Rombos Y; Vayopoulos G; Meletis J; Avlami A
    Chemotherapy; 1991; 37(5):376-81. PubMed ID: 1804599
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.